A postoperative prognostic nomogram for renal cell carcinoma

被引:593
|
作者
Kattan, MW
Reuter, V
Motzer, RJ
Katz, J
Russo, P
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, New York, NY 10021 USA
关键词
carcinoma; renal cell; neoplasms; abnormalities;
D O I
10.1016/S0022-5347(05)66077-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Few published studies have combined prognostic factors to predict the likelihood of recurrence after surgery for renal cell carcinoma. We developed a nomogram for this purpose. Materials and Methods: With Cox proportional hazards regression analysis, we modeled pathological data and disease followup for 601 patients with renal cell carcinoma who were treated with nephrectomy. Predictor variables were patient symptoms, including incidental, local or systemic, histology, including chromophobe, papillary or conventional, tumor size, and pathological stage. Treatment failure was recorded when there was either clinical evidence of disease recurrence or death from disease. Validation was performed with a statistical (bootstrapping) technique. Results: Disease recurrence was noted in 66 of the 601 patients, and those in whom treatment was successful had a median and maximum followup of 40 and 123 months, respectively. The 5-year probability of freedom from failure for the patient cohort was 86% (95% confidence interval 82 to 89). With statistical validation, predictions by the nomogram appeared accurate and discriminating with an area under the receiver operating characteristic curve, that is a comparison of the predicted probability with the actual outcome of 0.74. Conclusions: A nomogram has been developed that can be used to predict the 5-year probability of treatment failure among patients with newly diagnosed renal cell carcinoma. The nomogram may be useful for patient counseling, clinical trial design and patient followup planning.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 50 条
  • [21] Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma
    Mian, BM
    Bhadkamkar, N
    Slaton, JW
    Pisters, PWT
    Daliani, D
    Swanson, DA
    Pisters, LL
    JOURNAL OF UROLOGY, 2002, 167 (01) : 65 - 70
  • [22] Prognostic significance of the 1997 TNM classification of renal cell carcinoma
    Javidan, J
    Stricker, HJ
    Tamboli, P
    Amin, MB
    Peabody, JO
    Deshpande, A
    Menon, M
    Amin, MB
    JOURNAL OF UROLOGY, 1999, 162 (04) : 1277 - 1281
  • [23] New prognostic model for synchronous metastatic renal cell carcinoma
    Naito, Sei
    Kato, Tomoyuki
    Ichiyanagi, Osamu
    Narisawa, Takafumi
    Kurokawa, Masayuki
    Yagi, Mayu
    Ushijima, Masaki
    Ozawa, Michinobu
    Kanno, Hidenori
    Kurota, Yuta
    Fukuhara, Hiroki
    Kuboki, Yuya
    Yamagishi, Atsushi
    Sakurai, Toshihiko
    Nishida, Hayato
    Yamanobe, Takuya
    Tsuchiya, Norihiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (05) : 448 - 456
  • [24] Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma
    Yan, Yi
    Liu, Longfei
    Zhou, Jingyu
    Li, Liling
    Li, Yuan
    Chen, Minfeng
    Wang, Long
    He, Wei
    Guan, Xiao
    Zu, Xiongbing
    Qi, Lin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (02) : 345 - 352
  • [25] Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma
    Fukushima, Hiroshi
    Nakanishi, Yasukazu
    Kataoka, Madoka
    Tobisu, Ken-ichi
    Koga, Fumitaka
    JOURNAL OF UROLOGY, 2016, 195 (01) : 26 - 32
  • [26] Prognostic Significance of Biallelic Loss of PTEN in Clear Cell Renal Cell Carcinoma
    Lee, Hee Jin
    Lee, Ho Yun
    Lee, Jeong Hee
    Lee, Hajeong
    Kang, Guhyun
    Song, Joon Seon
    Kang, Jun
    Kim, Ju Han
    JOURNAL OF UROLOGY, 2014, 192 (03) : 940 - 946
  • [27] Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy
    Tatokoro, Manabu
    Saito, Kazutaka
    Iimura, Yasumasa
    Fujii, Yasuhisa
    Kawakami, Satoru
    Kihara, Kazunori
    JOURNAL OF UROLOGY, 2008, 180 (02) : 515 - 519
  • [28] A case of renal transitional cell carcinoma associated with synchronous contralateral renal cell carcinoma
    Hong, SK
    Jeong, SJ
    Lee, SE
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (01) : 108 - 110
  • [29] Low clinical stage renal cell carcinoma:: Relevance of microvascular tumor invasion as a prognostic parameter
    Gonçalves, PD
    Srougi, M
    Dall'Oglio, MF
    Leite, KRM
    Ortiz, V
    Hering, F
    JOURNAL OF UROLOGY, 2004, 172 (02) : 470 - 474
  • [30] Prognostic significance of CD44 molecule in renal cell carcinoma
    Lucin, K
    Matusan, K
    Dordevic, G
    Stipic, D
    CROATIAN MEDICAL JOURNAL, 2004, 45 (06) : 703 - 708